Published: Sun, January 14, 2018
Health | By Jay Jacobs

Walgreens Boots Alliance Inc (WBA) Stake Lowered by Klingenstein Fields & Co. LLC

Walgreens Boots Alliance Inc (WBA) Stake Lowered by Klingenstein Fields & Co. LLC

Accern also assigned headlines about the pharmacy operator an impact score of 45.9157853199944 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company's share price in the next several days. Concert Wealth Management Inc. purchased a new position in Walgreens Boots Alliance during the first quarter valued at approximately $261,000. Zions Bancorporation lifted its holdings in Walgreens Boots Alliance by 983.3% during the 3rd quarter.

Institutions own 97.20% of Baker Hughes, a GE company (BHGE)'s shares. Wellington Management Group LLP increased its holdings in Walgreens Boots Alliance by 5.9% in the 1st quarter. Following the transaction, the director now directly owns 16,415 shares of the company's stock, valued at $1,105,878.55. The shares were purchased at an average price of $80.68 per share, for a total transaction of $48,408.00. A low price-to-sales ratio, typically less than 1.0, is considered a good value. The disclosure for this sale can be found here. Insiders own 14.80% of the company's stock. WBA plunged -5.18% to $71.60. Noting its average daily volume at 6.08 million shares each day over the month, this signifies a pretty significant change over the norm. The company has a consensus rating of "Buy" and an average price target of $91.48. The company has a current ratio of 1.07, a quick ratio of 0.59 and a debt-to-equity ratio of 0.45. Walgreens Boots Alliance has a twelve month low of $63.82 and a twelve month high of $88.00. When looking at Walgreens Boots Alliance, Inc., the first item you can quickly note is the 19.99, which will give you a multiple that can be use to compare Walgreens Boots Alliance, Inc. against others in the Drug Stores or Services.

The Deerfield, IL-based drugstore chain reported Q1 earnings per share (EPS) of $1.28, which was $0.02 better than the Wall Street consensus estimate of $1.26.

Net sales rose 7.9 pct to $30.74 billion. During the same period in the prior year, the business posted $1.07 earnings per share. equities research analysts forecast that Walgreens Boots Alliance Inc will post 5.54 EPS for the current year.

Walgreens Boots Alliance announced that its board has initiated a share repurchase program on Wednesday, October 25th that allows the company to buyback $1.00 billion in shares. In the past 13-year record, this ratio went down as low as 0.36 and as high as 1.08.

The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 12th.

On 10/25/2017 announced a quarterly dividend of $0.40 2.31% with an ex dividend date of 11/10/2017 which will be payable on 11/13/2017. WBA attains analyst recommendation of 2.20 with week's performance of -1.73%. Over time, the acquisition could produce $300 million in annual cost-saving synergies for Walgreens Boots Alliance. (WBA) worth $1.27 billion at the end of the most recent reporting period.

The price target set for the stock is $85.67 and this sets up an interesting set of potential movement for the stock, according to data from Finviz's Research. Finally, Raymond James Financial restated a "market perform" rating on shares of Walgreens Boots Alliance in a report on Wednesday, September 27th. 10 of them rate its stock a hold. Walgreens Boots Alliance has an average rating of "Buy" and a consensus price target of $86.60.

COPYRIGHT VIOLATION WARNING: This piece was first posted by TrueBlueTribune and is the sole property of of TrueBlueTribune. If you are reading this report on another website, it was illegally copied and reposted in violation of United States and worldwide trademark & copyright laws. Walgreens Boots Alliance earned a coverage optimism score of 0.16 on Accern's scale. Andra AP fonden lifted its holdings in shares of Walgreens Boots Alliance by 35.3% in the second quarter. "As a health and wellbeing company, we operate in markets where ethical behavior is of utmost importance". Specifically, Walgreens' first quarter pharmacy sales jumped 8.9 percent year over year to $22.5 billion. The Company's products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Like this: